Mitochondrial dysfunction in heart failure: potential for therapeutic interventions?
Stanley
W C
WC
Hoppel
C L
CL
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D004734:Energy Metabolism; D006333:Heart Failure / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism*; D017240:Mitochondrial Myopathies / Q000188:drug therapy / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D011773:Pyruvates; D000255:Adenosine Triphosphate; D008790:Metoprolol